Seleccione un Tamaño
| Tamaño de envase | SKU | Disponibilidad | Precio |
|---|---|---|---|
| 50 mg | Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad | 90,60 € | |
| 1 g | Comprobar disponibilidad del carrito | 116,00 € |
Acerca de este artículo
90,60 €
Quality Segment
assay
≥98%
form
powder
drug control
USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal), kontrollierte Droge in Deutschland
color
white to off-white
solubility
H2O: 50 mg/mL, clear, colorless to yellow
originator
Novartis
SMILES string
Cl.CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2
InChI
1S/C21H27NO.ClH/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19;/h6-15,17H,5,16H2,1-4H3;1H
InChI key
FJQXCDYVZAHXNS-UHFFFAOYSA-N
Gene Information
human ... OPRM1(4988)
Biochem/physiol Actions
Features and Benefits
Legal Information
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.
English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.
1 of 1
Este artículo | |||
|---|---|---|---|
| form powder | form - | form - | form powder |
| assay ≥98% | assay - | assay - | assay ≥98% (HPLC) |
| drug control USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal) | drug control USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal) | drug control USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal) | drug control USDEA Schedule I; psicótropo (Spain); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 100 |
| solubility H2O: 50 mg/mL, clear, colorless to yellow | solubility - | solubility H2O: >10 mg/mL | solubility H2O: ≥30 mg/mL |
| originator Novartis | originator Sanofi Aventis | originator - | originator - |
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Oral - STOT SE 3
target_organs
Central nervous system
Clase de almacenamiento
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Datasheet
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| M0267-50MG | 04061835370276 |
| M0267-1G | 04061833992890 |




